You are here: Industry Insights > NIH

News List

NIH pauses Covid-19 convalescent plasma trial pharmaceutical-technology
March 04, 2021
The US National Institutes of Health (NIH) has put on hold a trial of convalescent blood plasma in treating patients with mild-to-moderate Covid-19 symptoms as the study provided no significant benefit in this group.
Moderna sends South Africa variant-specific vaccine for clinical study pharmatimes
February 26, 2021
Moderna has shipped doses of a variant-specific vaccine candidate against the COVID-19 variant first discovered in South Africa, otherwise known as B.1.351, to the US National Institutes of Health (NIH) for clinical study.
NIH study finds severe Covid-19 during pregnancy leads to complications pharmaceutical-business-review
February 03, 2021
Preliminary findings from a study funded by the National Institutes of Health (NIH) has found that pregnant women with severe Covid-19 symptoms had a higher risk of complications during and after pregnancy.
Syntegra collaborates with US NIH to increase access to Covid-19 data pharmaceutical-technology
January 20, 2021
Syntegra and the US National Institutes of Health (NIH) have collaborated to expand access to the largest set of Covid-19 patient records using the former’s AI-enabled synthetic data technology.
Irisys Receives NIH Contract for the Formulation of Drinabant contractpharma
January 12, 2021
Irisys LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, has been awarded a contract valued at $850,000 by the National Center for Advancing Translational Sciences (NCATS) ...
Soterix Medical Expands Clinical Trials for Alzheimer's Disease, Cognitive Impairment americanpharmaceuticalreview
December 31, 2020
Soterix Medical has reported expanded clinical trials of its proprietary neuromodulation technologies for Alzheimer's disease and Mild Cognitive Impairment.
NIH-sponsored trials evaluate monoclonal antibodies for Covid-19 treatment pharmaceutical-technology
December 18, 2020
The National Institutes of Health (NIH) in the US has announced the initiation of two Phase III clinical trials analysing investigational monoclonal antibodies for treating people hospitalised with moderate Covid-19.
eTrueNorth Recruiting COVID-Positive Individuals for ACTIV-2 Clinical Trial prnewswire
December 15, 2020
eTrueNorth, the U.S.-based healthcare technology company that enables laboratory testing at retail pharmacies and enables all surge drive-through COVID-19 specimen collection sites, will begin proactively communicating with COVID-19 positive ...
NIH begins large clinical trial to test immune modulators for treatment of COVID-19 worldpharmanews
October 21, 2020
The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.
First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine americanpharmaceuticalreview
October 15, 2020
The CoVIg-19 Plasma Alliance, a collaboration of plasma companies supported by organizations outside the plasma industry, confirmed patients are now being enrolled in the Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) ...

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page